Who backs Transition Bio?
6 investors| Investor | Type |
|---|---|
| Bristol-Myers Squibb | — |
| Lifeforce Capital | Venture capital |
| Magnetic Ventures | Venture capital |
| Northpond Ventures | — |
| Taiho Ventures | — |
| University of Cambridge | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Transition Bio investors
6 investors are on record for Transition Bio, including Bristol-Myers Squibb, Lifeforce Capital, Magnetic Ventures and Northpond Ventures. The early-stage round in Oct 2024 drew 8 investors.
Free account
More of Transition Bio with a free account
- ·Watch Transition Bio: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 6 firms already write checks for companies like Transition Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View